Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Fenfluramine hydrochloride

EU orphan designation number: EU/3/13/1219   
Active ingredient: Fenfluramine hydrochloride
Indication: Treatment of Dravet syndrome
Sponsor: Brabant Pharma Limited
Century House, Wargrave Road, Henley-on-Thames, RG9 2LT, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
03/01/2014 Orphan Designation EMA/OD/140/13 (2013)9709 of 18/12/2013